Loading
Latest filing published 03 Dec 2025 for NurExone Biologic Inc formerly, EnerSpar Corp, €65k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Eran Ovadya on record concern NurExone Biologic Inc. (formerly, EnerSpar Corp.). Over a trading history stretching from 15 June 2022 to 26 November 2025, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 3 December 2025 with a share grant (€65k) in NurExone Biologic Inc. (formerly, EnerSpar Corp.). This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations